|
MD Scientific, LLC is a North Carolina limited liability company established in 2003 for the purpose of advancing medicine through physician developed technology. In 2004, MD Scientific introduced an FDA cleared software, EndoTool®, a sophisticated software system that calculates the dose of IV insulin needed to quickly control blood glucose levels in acute, OR and critical care settings. EndoTool® Glucose Management System is one of the first software systems used therapeutically in hospital and rapidly became an important part of many hospital initiatives to improve glucose control of critically ill patients. MD Scientific sold its software business including the EndoTool® technology to Hospira Inc. in October 2008.
THE BOSS TRIAL
MD Scientific is sponsoring a Phase III clinical trial. The BOSS Trial in progress is under FDA IND 104,899 and is designed to evaluate sodium bicarbonate to reduce progression of chronic kidney disease (CKD) in subjects with advanced CKD who are undergoing angiography. Details of this clinical trial can be found at: http://www.clinicaltrials.gov/ |
|
BOSS TRIAL LEADERSHIP TEAM:
Co-Lead Principal Investigators:
Richard J. Solomon, MD, U. of Vermont
Harold L. Dauerman, MD, U. of Vermont
MD Scientific, LLC - Sponsor:
W. Patrick Burgess, PhD, MD, CMO
Shade M. Mecum, President, CEO
Lance B. Wyatt, Manufacturing and Regulatory
FDA Consultant:
Bert Spilker, PhD MD
Contract Research Organization:
Amarex Clinical Research, Germantown, MD
Investigational Drug Manufacturer:
Hospira, Inc. Lake Forest, Il
|
